A carregar...
Metformin treatment reduces temozolomide resistance of glioblastoma cells
It has been reported that metformin acts synergistically with temozolomide (TMZ) to inhibit proliferation of glioma cells including glioblastoma multiforme (GBM). However, the molecular mechanism underlying how metformin exerts its anti-cancer effects remains elusive. We used a combined experimental...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5346677/ https://ncbi.nlm.nih.gov/pubmed/27791206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12859 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|